Low risk — use of or exposure to this product is not likely to cause adverse health consequences.
Imodium Multi-Symptom Relief Caplets Recalled by Mcneil Consumer Healthcare, Div Of Mcneil-ppc, Inc. Due to Defective Container; damaged blister units
What You Should Do
Stop using this product immediately. Do not consume, use, or distribute it.
Return the product to the place of purchase for a full refund. If you have questions, contact Mcneil Consumer Healthcare, Div Of Mcneil-ppc, Inc. directly.
Affected Products
Imodium Multi-Symptom Relief Caplets, Loperamide HCl 2 mg/Simethicone 125 mg, 18 count blister pack cartons, McNeil Consumer Healthcare, Div of McNeil-PPC Inc., Fort Washington, PA
Quantity: 53,892 packages
Why Was This Recalled?
Defective Container; damaged blister units
Where Was This Sold?
This product was distributed nationwide across all 50 states.
About Mcneil Consumer Healthcare, Div Of Mcneil-ppc, Inc.
Mcneil Consumer Healthcare, Div Of Mcneil-ppc, Inc. has 2 total recalls tracked by RecallDetector.
Related Recalls
Icosapent Ethyl Capsules Recalled by Zydus Pharmaceuticals (USA) Inc Due to Failed Tablet/Capsule specifications: Red dots inside capsule and...
Zydus Pharmaceuticals (USA) Inc · March 9, 2026
Product label: Temozolomide Capsules Recalled by Rising Pharma Holding, Inc. Due to Failed Impurities/Degradation Specifications: An out-of-specification result observed during...
Rising Pharma Holding, Inc. · March 3, 2026
Semaglutide Inj. Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Data sourced from the FDA (Drug). Last updated March 26, 2026. View original report